2026 Global: Orthopedic Devices Market-Competitive Review (2032) report
Description
The 2026 Global: Orthopedic Devices Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
The top ten orthopedic device companies by revenue are Stryker, Johnson & Johnson MedTech, Zimmer Biomet, Smith+Nephew, Medtronic, Arthrex, Globus Medical, Enovis, Embla Medical, and Orthofix. Stryker Corporation, headquartered in Portage, Michigan, United States, leads the market with $22.6 billion in orthopedic revenue. The company generates over 40% of its total revenues from orthopedic surgery products, including implants for total joint replacements in the hip, knee, and shoulder, as well as trauma and extremities surgeries. Johnson & Johnson MedTech, part of the multinational Johnson & Johnson corporation based in New Jersey, United States, ranks second with $9.2 billion in orthopedic revenue. Through its DePuy Synthes subsidiary, headquartered in Raynham, Massachusetts, United States, the company holds approximately 35% of the orthopedic trauma device market and offers a comprehensive portfolio spanning craniomaxillofacial, spinal surgery, joint reconstruction, trauma, and sports medicine. Zimmer Biomet, headquartered in Warsaw, Indiana, United States, follows with $7.7 billion in revenue and holds the third-leading position in the orthopedic trauma market with under 15% share. Smith+Nephew, based in London, United Kingdom, generates $5.8 billion in orthopedic revenue and holds the second leading position in soft tissue repair and reconstruction with nearly 21% market share.
Medtronic, headquartered in Minneapolis, Minnesota, United States, contributes $5 billion to the orthopedic sector and leads the orthopedic biomaterials market with approximately 21% share. Arthrex, located in Naples, Florida, United States, generates $3.2 billion in orthopedic revenue and dominates the soft tissue repair and reconstruction market with almost 43% market share. The company develops over 1,000 products and procedures annually and operates medical education programs across six ArthroLab locations globally. Globus Medical, headquartered in Audubon, Pennsylvania, United States, produces $2.5 billion in orthopedic revenue and specializes in musculoskeletal device solutions focusing on biologics, spine, trauma, and joint reconstruction technology. Enovis, based in Wilmington, Delaware, United States, generates $2.1 billion in orthopedic sales and offers over 1,000 products including shockwave therapy devices and augmented reality guidance systems for knee and hip replacement surgery.
Embla Medical, the new parent name for Össur's operations, headquartered in Reykjavik, Iceland, produces $855 million in orthopedic revenue, focusing on prosthetics and osteoarthritis solutions. Finally, Orthofix, headquartered in Lewisville, Texas, United States, generates $799.5 million in orthopedic revenue and specializes in spine and limb reconstruction with a comprehensive portfolio of spinal hardware, bone growth therapies, and biologics. These ten companies collectively dominate the global orthopedic device market, with the majority headquartered in the United States, reflecting the country's prominence as a center for medical device innovation and manufacturing.
The top ten orthopedic device companies by revenue are Stryker, Johnson & Johnson MedTech, Zimmer Biomet, Smith+Nephew, Medtronic, Arthrex, Globus Medical, Enovis, Embla Medical, and Orthofix. Stryker Corporation, headquartered in Portage, Michigan, United States, leads the market with $22.6 billion in orthopedic revenue. The company generates over 40% of its total revenues from orthopedic surgery products, including implants for total joint replacements in the hip, knee, and shoulder, as well as trauma and extremities surgeries. Johnson & Johnson MedTech, part of the multinational Johnson & Johnson corporation based in New Jersey, United States, ranks second with $9.2 billion in orthopedic revenue. Through its DePuy Synthes subsidiary, headquartered in Raynham, Massachusetts, United States, the company holds approximately 35% of the orthopedic trauma device market and offers a comprehensive portfolio spanning craniomaxillofacial, spinal surgery, joint reconstruction, trauma, and sports medicine. Zimmer Biomet, headquartered in Warsaw, Indiana, United States, follows with $7.7 billion in revenue and holds the third-leading position in the orthopedic trauma market with under 15% share. Smith+Nephew, based in London, United Kingdom, generates $5.8 billion in orthopedic revenue and holds the second leading position in soft tissue repair and reconstruction with nearly 21% market share.
Medtronic, headquartered in Minneapolis, Minnesota, United States, contributes $5 billion to the orthopedic sector and leads the orthopedic biomaterials market with approximately 21% share. Arthrex, located in Naples, Florida, United States, generates $3.2 billion in orthopedic revenue and dominates the soft tissue repair and reconstruction market with almost 43% market share. The company develops over 1,000 products and procedures annually and operates medical education programs across six ArthroLab locations globally. Globus Medical, headquartered in Audubon, Pennsylvania, United States, produces $2.5 billion in orthopedic revenue and specializes in musculoskeletal device solutions focusing on biologics, spine, trauma, and joint reconstruction technology. Enovis, based in Wilmington, Delaware, United States, generates $2.1 billion in orthopedic sales and offers over 1,000 products including shockwave therapy devices and augmented reality guidance systems for knee and hip replacement surgery.
Embla Medical, the new parent name for Össur's operations, headquartered in Reykjavik, Iceland, produces $855 million in orthopedic revenue, focusing on prosthetics and osteoarthritis solutions. Finally, Orthofix, headquartered in Lewisville, Texas, United States, generates $799.5 million in orthopedic revenue and specializes in spine and limb reconstruction with a comprehensive portfolio of spinal hardware, bone growth therapies, and biologics. These ten companies collectively dominate the global orthopedic device market, with the majority headquartered in the United States, reflecting the country's prominence as a center for medical device innovation and manufacturing.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
